6 studies found for:    14691125 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Prospective Multi-center Phase III Randomized Controlled Trial
Condition: Carcinoma,Non-Small-Cell Lung
Interventions: Drug: cisplatin and pemetrexed;   Drug: nadaplatin+pemetrexed
2 Recruiting Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer
Condition: Non-small-cell Lung Cancer
Interventions: Drug: Nimotuzumab;   Drug: docetaxel and cisplatin;   Radiation: daily RT (65Gy in 25 fractions) to the chest;   Drug: placebo
3 Recruiting Study of Consolidation Chemotherapy For Bulky Local Advanced None-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: consolidation chemotherapy of AP or DP after CCRT;   Radiation: chest radiation;   Drug: weekly DP concurrent with chest radiation
4 Completed
Has Results
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
Conditions: NSCLC;   Solid Tumors
Interventions: Drug: YM155;   Drug: Carboplatin;   Drug: Paclitaxel
5 Unknown  Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: erlotinib;   Procedure: FDG-/FLT-PET
6 Active, not recruiting Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Taxol (paclitaxel);   Procedure: Radiotherapy;   Drug: Carboplatin;   Drug: Gemcitabine

Indicates status has not been verified in more than two years